Company Intercept Pharmaceuticals, Inc.
Equities
ICPT
US45845P1084
Biotechnology & Medical Research
Business Summary
Number of employees: 341
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23/17/23 |
Andrew Saik
DFI | Director of Finance/CFO | 54 | 21/21/21 |
M. Berrey
CTO | Chief Tech/Sci/R&D Officer | 57 | 09/21/09 |
Jose Truzman
SEC | Corporate Secretary | - | - |
Rocco Venezia
AUD | Comptroller/Controller/Auditor | 48 | 01/16/01 |
General Counsel | 55 | 11/21/11 | |
Corporate Officer/Principal | 60 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 23/17/23 |
Director/Board Member | 55 | 08/11 | |
Stefano Pasi
BRD | Director/Board Member | - | 08/11 |
Michele Cera
BRD | Director/Board Member | - | 08/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,825,966 | 40,940,614 ( 97.88 %) | 0 | 97.88 % |
Company contact information
Intercept Pharmaceuticals, Inc.
305 Madison Avenue
07960, Morristown
+646 747 1000
http://www.interceptpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.64% | 22.15B | |
-17.37% | 21.02B | |
-8.47% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |